Nazzari Elena, Casabella Andrea, Paolino Sabrina, Campana Claudia, Corica Giuliana, Nista Federica, Milioto Angelo, Tagliafico Alberto, Albertelli Manuela, Boschetti Mara, Bagnasco Marcello, Cutolo Maurizio, Ferone Diego, Gatto Federico
Endocrinology and Diabetology, ASL2 Savonese, 17100 Liguria, Italy.
Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.
J Clin Med. 2022 Oct 28;11(21):6374. doi: 10.3390/jcm11216374.
Although GH and IGF-1 excess has a controversial impact on bone mineral density (BMD), acromegalic patients display variable degrees of bone structure impairment. In this study, we aim to investigate the usefulness of trabecular bone score (TBS), compared to BMD, in identifying acromegalic patients with impaired lumbar spine trabecular microarchitecture. Forty-four acromegalic patients were investigated for disease control, metabolic and gonadal status, bone metabolism parameters, and the presence of vertebral fractures (VFs). Patients and matched healthy controls underwent BMD and TBS examination. Mean TBS values were lower in patients than in controls (p < 0.001), without significant differences in mean lumbar and femoral BMD. TBS values were significantly higher in controlled patients compared to the uncontrolled ones (p = 0.012). No significant differences were found in bone markers with respect to disease control. Mean TBS or lumbar BMD did not significantly differ in patients with or without VFs (prevalence 11.4%). TBS and BMD levels were lower in hypogonadal patients compared to the eugonadal ones (p = 0.030 and p < 0.001, respectively). In conclusion, TBS values are significantly lower in patients than in controls, confirming the presence of impaired lumbar spine trabecular bone in acromegaly. Both uncontrolled disease and hypogonadism contribute to TBS deterioration in acromegaly.
尽管生长激素(GH)和胰岛素样生长因子-1(IGF-1)过多对骨密度(BMD)的影响存在争议,但肢端肥大症患者表现出不同程度的骨结构损害。在本研究中,我们旨在探讨与骨密度相比,小梁骨评分(TBS)在识别腰椎小梁微结构受损的肢端肥大症患者中的作用。对44例肢端肥大症患者进行了疾病控制、代谢和性腺状态、骨代谢参数以及椎体骨折(VF)情况的调查。患者和匹配的健康对照者均接受了骨密度和小梁骨评分检查。患者的平均小梁骨评分值低于对照组(p < 0.001),而腰椎和股骨的平均骨密度无显著差异。与未得到控制的患者相比,病情得到控制的患者小梁骨评分值显著更高(p = 0.012)。在疾病控制方面,骨标志物未发现显著差异。有或无椎体骨折的患者(患病率11.4%),其平均小梁骨评分或腰椎骨密度无显著差异。性腺功能减退的患者与性腺功能正常的患者相比,小梁骨评分和骨密度水平更低(分别为p = 0.030和p < 0.001)。总之,患者的小梁骨评分值显著低于对照组,证实肢端肥大症患者存在腰椎小梁骨受损。疾病未得到控制和性腺功能减退均会导致肢端肥大症患者小梁骨评分恶化。